Predicting outcome of depression using the depressive symptom profile: The Leiden routine outcome monitoring study

Depression and Anxiety

Volumn 29, Issue 6, 2012, Pages 523-530

  Van Noorden, Martijn S ^a   Van Fenema, Esther M ^a   Van Der Wee, Nic J A ^a,b   Zitman, Frans G ^a,c   Giltay, Erik J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c Rivierduinen   (Netherlands)

Author keywords

Depression; dysthymic disorder; Epidemiology; mood disorders; treatment

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGED; ANXIETY; ARTICLE; AVOIDANCE BEHAVIOR; BECK DEPRESSION INVENTORY; BORDERLINE STATE; COHORT ANALYSIS; COMORBIDITY; DYSTHYMIA; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MARRIAGE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PATIENT MONITORING; PESSIMISM; PREDICTION; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; REMISSION; SELF REPORT; SUICIDE;

EID: 85027924854     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.21958     Document Type: Article

References (55)

1. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006; 163: 1905-1917. (Pubitemid 44807782)
2. Rush AJ, Laux G, Giles DE, et al. Clinical characteristics of outpatients with chronic major depression. J Affect Disord 1995; 34: 25-32.
3. Thase ME,. Achieving remission and managing relapse in depression. J Clin Psychiatry 2003; 64 (Suppl 18): 3-7.
4. Wittchen HU, Jacobi F, Rehm J, et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011; 21: 655-679.
5. McKenzie M, Clarke DM, McKenzie DP, Smith GC,. Which factors predict the persistence of DSM-IV depression, anxiety, and somatoform disorders in the medically ill three months post hospital discharge? J Psychosom Res 2010; 68: 21-28.
6. Barkow K, Maier W, Ustun TB, Gansicke M, Wittchen HU, Heun R,. Risk factors for depression at 12-month follow-up in adult primary health care patients with major depression: an international prospective study. J Affect Disord 2003; 76: 157-169. (Pubitemid 37013368)
7. Fournier JC, DeRubeis RJ, Shelton RC, Hollon SD, Amsterdam JD, Gallop R,. Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression. J Consult Clin Psychol 2009; 77: 775-787.
8. Sherbourne C, Schoenbaum M, Wells KB, Croghan TW,. Characteristics, treatment patterns, and outcomes of persistent depression despite treatment in primary care. Gen Hosp Psychiatry 2004; 26: 106-114. (Pubitemid 38369116)
9. Frank E, Cassano GB, Rucci P, et al. Predictors and moderators of time to remission of major depression with interpersonal psychotherapy and SSRI pharmacotherapy. Psychol Med 2011; 41: 151-162.
10. Meyers BS, Sirey JA, Bruce M, et al. Predictors of early recovery from major depression among persons admitted to community-based clinics: an observational study. Arch Gen Psychiatry 2002; 59: 729-735. (Pubitemid 34847946)
11. Weinberger MI, Sirey JA, Bruce ML, Heo M, Papademetriou E, Meyers BS,. Predictors of major depression six months after admission for outpatient treatment. Psychiatr Serv 2008; 59: 1211-1215.
12. Moos RH, Cronkite RC,. Symptom-based predictors of a 10-year chronic course of treated depression. J Nerv Ment Dis 1999; 187: 360-368. (Pubitemid 29272887)
13. Sargeant JK, Bruce ML, Florio LP, Weissman MM,. Factors associated with 1-year outcome of major depression in the community. Arch Gen Psychiatry 1990; 47: 519-526. (Pubitemid 20189963)
14. Enns MW, Cox BJ,. Psychosocial and clinical predictors of symptom persistence vs remission in major depressive disorder. Can J Psychiatry 2005; 50: 769-777. (Pubitemid 43161771)
15. Melartin TK, Rytsala HJ, Leskela US, Lestela-Mielonen PS, Sokero TP, Isometsa ET,. Severity and comorbidity predict episode duration and recurrence of DSM-IV major depressive disorder. J Clin Psychiatry 2004; 65: 810-819.
16. Souery D, Oswald P, Massat I, et al. Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study. J Clin Psychiatry 2007; 68: 1062-1070. (Pubitemid 47340327)
17. Vuorilehto MS, Melartin TK, Isometsa ET,. Course and outcome of depressive disorders in primary care: a prospective 18-month study. Psychol Med 2009; 39: 1697-1707.
18. Uher R, Perlis RH, Henigsberg N, et al. Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms. Psychol Med 2011; 1-14.
19. Penninx BW, Nolen WA, Lamers F, et al. Two-year course of depressive and anxiety disorders: results from the Netherlands Study of Depression and Anxiety (NESDA). J Affect Disord 2011; 133: 76-85.
20. Wiersma JE, Van OP, Van Schaik DJ, van der Does AJ, Beekman AT, Penninx BW,. Psychological characteristics of chronic depression: a longitudinal cohort study. J Clin Psychiatry 2011; 72: 288-294.
21. Skodol AE, Grilo CM, Keyes KM, Geier T, Grant BF, Hasin DS,. Relationship of personality disorders to the course of major depressive disorder in a nationally representative sample. Am J Psychiatry 2011; 168: 257-264.
22. van der Lem R, van der Wee NJ, van VT, Zitman FG,. The generalizability of antidepressant efficacy trials to routine psychiatric out-patient practice. Psychol Med 2011; 41: 1353-1363.
23. Beck AT, Steer RA, Carbin MG,. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clinical Psychology Review 1988; 8: 77-100. (Pubitemid 18045797)
24. de Beurs E, den Hollander-Gijsman ME, van Rood YR, et al. Routine outcome monitoring in the Netherlands: practical experiences with a web-based strategy for the assessment of treatment outcome in clinical practice. Clin Psychol Psychother 2011 18: 1-12.
25. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed -Text revision ed. Washington, DC: American Psychiatric Association 2000.
26. Lecrubier Y,. The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. European Psychiatry 1997; 12: 224 -231.
27. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59 (Suppl 20): 22-33. (Pubitemid 29001829)
28. van Vliet IM, de Beurs E,. The MINI-International Neuropsychiatric Interview. A brief structured diagnostic psychiatric interview for DSM-IV en ICD-10 psychiatric disorders. Tijdschr Psychiatr 2007; 49: 393-397. (Pubitemid 47039071)
29. van Noorden MS, Giltay EJ, den Hollander-Gijsman ME, der Wee NJ, van VT, Zitman FG,. Gender differences in clinical characteristics in a naturalistic sample of depressive outpatients: the Leiden Routine Outcome Monitoring Study. J Affect Disord 2010; 125: 116-123.
30. Montgomery SA,. A new depression scale designed to be sensitive to change. The British journal of psychiatry 1979; 134: 382 -389.
31. Zimmerman M, Chelminski I, Young D,. On the threshold of disorder: a study of the impact of the DSM-IV clinical significance criterion on diagnosing depressive and anxiety disorders in clinical practice. J Clin Psychiatry 2004; 65: 1400-1405.
32. Hawley CJ, Gale TM, Sivakumaran T,. Defining remission by cut off score on the MADRS: selecting the optimal value. J Affect Disord 2002; 72: 177-184. (Pubitemid 35012022)
33. Zimmerman M, Posternak MA, Chelminski I,. Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression. J Psychiatr Res 2004; 38: 577-582. (Pubitemid 39348889)
34. Nierenberg AA, DeCecco LM,. Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: a focus on treatment-resistant depression. J Clin Psychiatry 2001; 62 (Suppl 16): 5-9.
35. Beck AT, Steer RA, Brown OK,. Beck Depression Inventory Manual. 2nd ed. San Antonio, TX: Psychological Corporation; 1996.
36. Senn S,. Importance of trends in the interpretation of an overall odds ratio in the meta-analysis of clinical trials. Stat Med 1994; 13: 293-296. (Pubitemid 24038044)
37. Van Kampen D, De Beurs, E, Andrea H,. A short form of the Dimensional Assessment of Personality Pathology-Basic Questionnaire (DAPP-BQ): the DAPP-SF. Psychiatry Res 2008; 160: 115-128.
38. Tyrer P, Owen RT, Cicchetti DV,. The brief scale for anxiety: a subdivision of the comprehensive psychopathological rating scale. J Neurol Neurosurg Psychiatry 1984; 47: 970-975.
39. de Beurs E, Zitman FG,. The Brief Symptom Inventory (BSI): reliability and validity of a practical alternative to SCL-90. MGV 2006; 61: 120-141.
40. Derogatis LR, Melisaratos N,. The Brief Symptom Inventory: an introductory report. Psychol Med 1983; 13: 595-605. (Pubitemid 13019024)
41. Guy W., ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: National Institute of Mental Health; 1976.
42. Endicott J, Spitzer RL, Fleiss JL, Cohen J,. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976; 33: 766-771.
43. Keller F, Kempf W,. Some latent trait and latent class analyses of the Beck Depression Inventory. In:, Rost J, Langeheine R, editors. Applications of Latent Trait and Latent Class Models in the Social Sciences. Münster: Waxmann; 1997;314-323.
44. Wade AG, Schlaepfer TE, Andersen HF, Kilts CD,. Clinical milestones predict symptom remission over 6-month and choice of treatment of patients with major depressive disorder (MDD). J Psychiatr Res 2009; 43: 568-575.
45. Uher R, Farmer A, Maier W, et al. Measuring depression: comparison and integration of three scales in the GENDEP study. Psychol Med 2008; 38: 289-300. (Pubitemid 351156595)
46. Giltay EJ, Zitman FG, Kromhout D,. Dispositional optimism and the risk of depressive symptoms during 15 years of follow-up: the Zutphen Elderly Study. J Affect Disord 2006; 91: 45-52. (Pubitemid 43254637)
47. Schou I, Ekeberg O, Ruland CM, Sandvik L, Karesen R,. Pessimism as a predictor of emotional morbidity one year following breast cancer surgery. Psychooncology 2004; 13: 309-320. (Pubitemid 38714193)
48. Zenger M, Brix C, Borowski J, Stolzenburg JU, Hinz A,. The impact of optimism on anxiety, depression and quality of life in urogenital cancer patients. Psychooncology 2010; 19: 879-886.
49. Achat H, Kawachi I, Spiro A, III, DeMolles DA, Sparrow D,. Optimism and depression as predictors of physical and mental health functioning: the Normative Aging Study. Ann Behav Med 2000; 22: 127-130. (Pubitemid 32429377)
50. Karlsson H, Kronstrom K, Nabi H, et al. Low level of optimism predicts initiation of psychotherapy for depression: results from the Finnish Public Sector Study. Psychother Psychosom 2011; 80: 238-244.
51. Oquendo MA, Galfalvy H, Russo S, et al. Prospective study of clinical predictors of suicidal acts after a major depressive episode in patients with major depressive disorder or bipolar disorder. Am J Psychiatry 2004; 161: 1433-1441. (Pubitemid 38989097)
52. Newman CF, Beck AT,. Cognitive therapy. In:, Sadock BJ, Sadock VA, editors. Kaplan and Sadock's Comprehensive Textbook of Psychiatry. 9th ed. Baltimore: Lippincott Williams & Wilkins; 2009: 2858 -2873.
53. Rius-Ottenheim N, Kromhout D, van der Mast RC, Zitman FG, Geleijnse JM, Giltay EJ,. Dispositional optimism and loneliness in older men. Int J Geriatr Psychiatry 2012; 27: 151-159.
54. Leedham B, Meyerowitz BE, Muirhead J, Frist WH,. Positive expectations predict health after heart transplantation. Health Psychol 1995; 14: 74-79.
55. van der Lem R, van der Wee NJ, van VT, Zitman FG,. The generalizability of antidepressant efficacy trials to routine psychiatric out-patient practice. Psychol Med 2011; 41: 1353-1363.